The errors of our ways: taking account of error in computer-aided drug design to build confidence intervals for our next 25 years

The future of the advancement as well as the reputation of computer-aided drug design will be guided by a more thorough understanding of the domain of applicability of our methods and the errors and confidence intervals of their results. The implications of error in current force fields applied to drug design are given are given as an example. Even as our science advances and our hardware become increasingly more capable, our software will be perhaps the most important aspect in this realization. Some recommendations for the future are provided. Education of users is essential for proper use and interpretation of computational results in the future.

[1]  C. E. Peishoff,et al.  A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.

[2]  J. Guthrie,et al.  A blind challenge for computational solvation free energies: introduction and overview. , 2009, The journal of physical chemistry. B.

[3]  A. Tramontano,et al.  Critical assessment of methods of protein structure prediction (CASP)—round IX , 2011, Proteins.

[4]  David L Mobley,et al.  Comparison of charge models for fixed-charge force fields: small-molecule hydration free energies in explicit solvent. , 2007, The journal of physical chemistry. B.

[5]  Anthony Nicholls,et al.  SAMPL2 challenge: prediction of solvation energies and tautomer ratios , 2010, J. Comput. Aided Mol. Des..

[6]  Ajay N. Jain,et al.  Molecular Shape and Medicinal Chemistry: A Perspective , 2010, Journal of medicinal chemistry.

[7]  Arnold T. Hagler,et al.  New combining rules for rare gas van der waals parameters , 1993, J. Comput. Chem..

[8]  K. Dill,et al.  Predicting absolute ligand binding free energies to a simple model site. , 2007, Journal of molecular biology.

[9]  Terry R Stouch,et al.  An atomic and molecular view of the depth dependence of the free energies of solute transfer from water into lipid bilayers. , 2011, Molecular pharmaceutics.

[10]  K. Tang,et al.  The van der Waals potentials between all the rare gas atoms from He to Rn , 2003 .

[11]  Michael J. E. Sternberg,et al.  The 4th meeting on the Critical Assessment of Predicted Interaction (CAPRI) held at the Mare Nostrum, Barcelona , 2010 .

[12]  Claire S. Adjiman,et al.  Towards crystal structure prediction of complex organic compounds – a report on the fifth blind test , 2011, Acta crystallographica. Section B, Structural science.

[13]  Martha S. Head,et al.  Drug Design: Docking: a domesday report , 2010 .

[14]  Donald E. Williams,et al.  Failure of net atomic charge models to represent the van der Waals envelope electric potential of n‐alkanes , 1994, J. Comput. Chem..

[15]  Terry R Stouch,et al.  Functional group dependence of solute partitioning to various locations within a DOPC bilayer: a comparison of molecular dynamics simulations with experiment. , 2011, Journal of pharmaceutical sciences.

[16]  Yvonne C. Martin,et al.  Application of Belief Theory to Similarity Data Fusion for Use in Analog Searching and Lead Hopping , 2008, J. Chem. Inf. Model..

[17]  Scott P. Brown,et al.  A unified, probabilistic framework for structure- and ligand-based virtual screening. , 2011, Journal of medicinal chemistry.

[18]  Tejender S. Thakur,et al.  Significant progress in predicting the crystal structures of small organic molecules--a report on the fourth blind test. , 2009, Acta crystallographica. Section B, Structural science.

[19]  David L Mobley,et al.  Small molecule hydration free energies in explicit solvent: An extensive test of fixed-charge atomistic simulations. , 2009, Journal of chemical theory and computation.

[20]  Sarah L Price,et al.  A nonempirical anisotropic atom-atom model potential for chlorobenzene crystals. , 2003, Journal of the American Chemical Society.

[21]  Donald E. Williams,et al.  Effects of Molecular Electric Potential and Anisotropic Atomic Repulsion in the Dichlorine Dimer and Crystalline Chlorine , 1997 .

[22]  Ryan H. Lilien,et al.  Applying Medicinal Chemistry Transformations and Multiparameter Optimization to Guide the Search for High-Quality Leads and Candidates , 2011, J. Chem. Inf. Model..

[23]  Heather A. Carlson,et al.  A Call to Arms: What You Can Do for Computational Drug Discovery , 2011, J. Chem. Inf. Model..